Victory Capital Management
CKPT

Victory Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

Victory Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,358
Closed -$20K – 2655
2020
Q1 		$20K Buy
+1,358
New +$24K ﹤0.01% 3089
2019
Q4 		– Sell
-456
Closed -$11K – 2753
2019
Q3 		$11K Buy
+456
New +$12.5K ﹤0.01% 3220

Other funds holding CKPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Victory Capital Management's CKPT Position: Q2 2020 in Review

Victory Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2020, closing a stake of 1,358 shares — an estimated $20K sold.

Victory Capital Management first reported a position in CKPT in Q3 2019 and held it in 2 quarters. The position peaked at $20K in Q1 2020. 45 funds tracked by Wall St. Rank hold CKPT as of Q2 2020.

  • Victory Capital Management reported no remaining Checkpoint Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 1,358 Checkpoint Therapeutics shares in Q2 2020, an estimated $20K.
  • Victory Capital Management first reported a position in Checkpoint Therapeutics in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Checkpoint Therapeutics position peaked at $20K in Q1 2020.
  • 45 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.